Developments in HIV neuropathogenesis

Current Pharmaceutical Design
Jeffrey A Rumbaugh, A Nath

Abstract

Despite the fact that neurons are rarely infected by the human immunodeficiency virus (HIV), neuronal loss is common in patients with HIV infection, likely due to the effects of viral proteins and inflammatory mediators on these cells. Despite the widespread use of highly active antiretroviral therapy (HAART), at least in developed nations, cognitive impairment and other neurological complications of HIV infection persist with devastating personal and socioeconomic consequences. Fortunately, we have made important advances in recent years in defining the molecular mechanisms by which HIV infection targets the nervous system for damage. Such understanding has opened numerous therapeutic options, which are only now beginning to be exploited. This review will highlight the current state of thought regarding the neuropathogenesis of HIV infection. It will summarize the most recent research looking at the roles of both viral and host factors in mediating HIV-induced neurological disease. Utilizing this knowledge base, a framework will be outlined for current and future therapeutic trials to prevent or improve neurological complications of HIV infection.

Citations

Nov 20, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Jiqing Xu, Tsuneya Ikezu
Dec 27, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Kelly A MeulendykeM Christine Zink
Apr 22, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yu ZhuChristopher Power
Mar 27, 2012·TheScientificWorldJournal·Jean-Pierre Louboutin, David S Strayer
Sep 12, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Marilyn J DuncanKurt F Hauser
Oct 22, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Seth W PerryHarris A Gelbard
Dec 29, 2011·CNS Drugs·Ik L Tan, Justin C McArthur
Jul 13, 2014·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Vishnudutt PurohitJoni Rutter
Apr 2, 2014·The Journal of Infectious Diseases·Kelly A MeulendykeM Christine Zink
Jul 2, 2009·Expert Opinion on Drug Delivery·Kavitha S RaoVinod Labhasetwar
Nov 22, 2007·Trends in Molecular Medicine·Claudio M Mastroianni, Grazia M Liuzzi
Mar 10, 2007·Brain, Behavior, and Immunity·Kathy L KopniskyYu Woody Lin
Nov 10, 2013·Immunologic Research·Rebeca Geffin, Micheline McCarthy
Nov 19, 2011·The European Journal of Neuroscience·Jean-Pierre LouboutinDavid S Strayer
Oct 26, 2014·BMC Bioinformatics·Mohammad Ali Moni, Pietro Liò
Jul 2, 2016·Neurotoxicity Research·Ankit ShahAnil Kumar
Oct 22, 2009·Antiviral Chemistry & Chemotherapy·Christina Gavegnano, Raymond F Schinazi
Feb 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ziye SuiSanjay B Maggirwar

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.